Brett Einerson
( out of 39 reviews )

Brett Einerson, MD, MPH, FACOG

Languages spoken: English

Clinical Locations

Primary Location

U of U Health Elko Specialty Clinic

Maternal Fetal Medicine Outreach Clinic
247 Bluffs Ave
Elko , NV 89801
801-213-2995
Get Directions

University of Utah Hospital

University Maternal Fetal Medicine, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-213-2995
Get Directions

Dr. Einerson is a specialist and expert in maternal-fetal medicine who is dedicated to caring for both mothers and babies during high-risk pregnancies. He provides care to his patients with all types of high-risk pregnancy issues and specializes in placenta problems (including placenta accreta spectrum, placenta previa, and vasa previa), twin or triplet pregnancies, cervical insufficiency, and fetal genetic differences.

Throughout pregnancy, Dr. Einerson offers early ultrasounds, genetic screening, amniocentesis for genetic diagnosis, and treatments to help prevent preterm birth. He supports both vaginal and cesarean deliveries and specializes in complex deliveries, such as turning breech babies to head-down positions. Dr. Einerson is also experienced in managing placenta accreta spectrum with options ranging from cesarean hysterectomy to more conservative treatments when appropriate.

He sees patients for consultations and prenatal care and works with patients established with an OB/GYN or midwife. Dr. Einerson provides care at University of Utah Hospital in Salt Lake City and the University of Utah Specialty Clinic in Elko.

To schedule a consultation with Dr. Einerson, please call the Women’s Health Center at 801-213-2995 or the Elko Speciality Clinic at 801-581-3495.

Dr. Einerson earned his medical degree from Wake Forest University School of Medicine and a Master’s in Public Health in Health Care Leadership from the University of North Carolina at Chapel Hill. He completed his OB/GYN residency at Northwestern University Feinberg School of Medicine and continued his training with a fellowship in Maternal-Fetal Medicine at the University of Utah, where he now serves as faculty. Dr. Einerson is board-certified in both Obstetrics & Gynecology and Maternal-Fetal Medicine and is a Fellow of the American Congress of Obstetricians & Gynecologists (FACOG).

Research
Dr. Einerson is an Assistant Professor of Obstetrics & Gynecology in the Division of Maternal-Fetal Medicine at the University of Utah.

Dr. Einerson’s research focuses on placenta accreta spectrum, severe maternal morbidity, quality improvement and patient safety, obstetric and postpartum hemorrhage, and cost-effectiveness. He has ongoing funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, K23HD106009) to study alternative treatments for placenta accreta spectrum (PAS). He was the recipient of a career development award through the Maternal-Fetal Medicine Units (MFMU) Network to study the cost of care in patients undergoing induction of labor or expectant management at term in the ARRIVE trial. His research is supported by the University of Utah Vice President’s Clinical & Translational (VPCAT) Research Scholars Program and the Utah OB-GYN Research Network (OGRN). His peer reviewed research has been published in Obstetrics & Gynecology, The American Journal of Obstetrics & Gynecology (AJOG), the British Journal of Obstetrics & Gynecology (BJOG), and BMJ Open. In 2020, he received the Roy M. Pitkin Award on behalf of the department for an outstanding research publication in Obstetrics & Gynecology (PMID 32541288).

Dr. Einerson is a nationally recognized clinical expert in diagnosis and management of placenta accreta spectrum disorders (PAS). He is Director of the Utah Placenta Accreta Program at the University of Utah. As one of the busiest referral programs for PAS in the United States, the program provides internationally recognized, cutting-edge, interdisciplinary approaches to diagnosis, treatment, patient-centered support for those affected by PAS. He is a Board Member of the Pan-American Society for Placenta Accreta Spectrum (PAS2) and serves as that society’s Publications Committee Chair. In 2020 and 2021, he was co-director of the Society of Maternal Fetal Medicine (SMFM) Accreta Scientific Forum. In October 2022, he and the University of Utah hosted the 4th Annual National meeting of PAS2 in Salt Lake City, Utah. Given this expertise, he has been a speaker, lecturer, and podcast guest to discuss PAS for regional and national events including SMFM Post-Graduate Courses and Accreta Scientific Forum, the PAS2 National Conference, the Vanderbilt High Risk Pregnancy Seminar, the Park City Postgraduate OB-GYN Course, the Healthful Woman Podcast, and CREOGs Over Coffee Podcast.

Dr. Einerson is an engaged leader, award-winning educator, and effective mentor. He was a member of the SMFM Patient Safety and Quality Committee from 2016 to 2022, where he authored the SMFM Placenta Accreta Spectrum Safety Checklist. Locally, he is the Medical Director of Obstetric Emergency Services (OBES) at University of Utah Health, Chair of the University of Utah Severe Maternal Morbidity Review Committee, and Member of the University Transfusion Committee. He is Associate Program Director (Research) for the University of Utah Maternal-Fetal Medicine (MFM) Fellowship.

A devoted medical educator, he has received eight teaching awards from medical students and residents, including twice being named the recipient of the National Faculty Award from the American College of Obstetricians and Gynecologists (ACOG) and Council on Resident Education in Obstetrics & Gynecology (CREOG) for promoting high standards of residency education in the field of obstetrics and gynecology.

Link to his research at: Google Scholar | Scopus | ORCID

 

Specialties

Board Certification

American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)
American Board of Obstetrics & Gynecology

Patient Rating

4.9 /5
( out of 39 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

UNIVERSITY HOSPITAL

Dr. Einerson is a great doctor and I look forward to continue to see him for the rest of my pregnancy.

UNIVERSITY HOSPITAL

He explained everything clearly and made sure all my questions were answered.

UNIVERSITY HOSPITAL

He's an excellent Doctor

UNIVERSITY HOSPITAL

Dr. Einerson was very thorough and took time to answer all of my questions.

UH HOSPITALS AND CLINICS

Dr. Einerson and his MA's are so caring and attentive. Dr. Einerson is so knowledgeable and always puts my mind at ease when answering tough questions.

UH HOSPITALS AND CLINICS

Dr. Einerson is amazing. My very 1st visit with him and I felt the welcomed. It felt as if I knew Dr. E for years. He did have a medical student and she was very nice to me and explained everything by a step by step basis. I know my risks and advantages of pregnancy. I have a clearer picture of what is in store for me.

EXTERNAL SITE

He is the best and his MA makes us feel welcomed and cared about ! Hes encouraging and gives me the confidence with my birth plan needed as a High Risk Patient . Ty Dr. Einerson and Blake ! For always reassuring us that the only stupid questions is not asking a question . Ty

EXTERNAL SITE

Amazing!

UH HOSPITALS AND CLINICS

Dr Einerson and his team are wonderful. In both the clinic and surgical setting. He listened to all of my questions and concerns and made sure I knew he cared.

Dr. Einerson is a specialist and expert in maternal-fetal medicine who is dedicated to caring for both mothers and babies during high-risk pregnancies. He provides care to his patients with all types of high-risk pregnancy issues and specializes in placenta problems (including placenta accreta spectrum, placenta previa, and vasa previa), twin or triplet pregnancies, cervical insufficiency, and fetal genetic differences.

Throughout pregnancy, Dr. Einerson offers early ultrasounds, genetic screening, amniocentesis for genetic diagnosis, and treatments to help prevent preterm birth. He supports both vaginal and cesarean deliveries and specializes in complex deliveries, such as turning breech babies to head-down positions. Dr. Einerson is also experienced in managing placenta accreta spectrum with options ranging from cesarean hysterectomy to more conservative treatments when appropriate.

He sees patients for consultations and prenatal care and works with patients established with an OB/GYN or midwife. Dr. Einerson provides care at University of Utah Hospital in Salt Lake City and the University of Utah Specialty Clinic in Elko.

To schedule a consultation with Dr. Einerson, please call the Women’s Health Center at 801-213-2995 or the Elko Speciality Clinic at 801-581-3495.

Dr. Einerson earned his medical degree from Wake Forest University School of Medicine and a Master’s in Public Health in Health Care Leadership from the University of North Carolina at Chapel Hill. He completed his OB/GYN residency at Northwestern University Feinberg School of Medicine and continued his training with a fellowship in Maternal-Fetal Medicine at the University of Utah, where he now serves as faculty. Dr. Einerson is board-certified in both Obstetrics & Gynecology and Maternal-Fetal Medicine and is a Fellow of the American Congress of Obstetricians & Gynecologists (FACOG).

Research
Dr. Einerson is an Assistant Professor of Obstetrics & Gynecology in the Division of Maternal-Fetal Medicine at the University of Utah.

Dr. Einerson’s research focuses on placenta accreta spectrum, severe maternal morbidity, quality improvement and patient safety, obstetric and postpartum hemorrhage, and cost-effectiveness. He has ongoing funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, K23HD106009) to study alternative treatments for placenta accreta spectrum (PAS). He was the recipient of a career development award through the Maternal-Fetal Medicine Units (MFMU) Network to study the cost of care in patients undergoing induction of labor or expectant management at term in the ARRIVE trial. His research is supported by the University of Utah Vice President’s Clinical & Translational (VPCAT) Research Scholars Program and the Utah OB-GYN Research Network (OGRN). His peer reviewed research has been published in Obstetrics & Gynecology, The American Journal of Obstetrics & Gynecology (AJOG), the British Journal of Obstetrics & Gynecology (BJOG), and BMJ Open. In 2020, he received the Roy M. Pitkin Award on behalf of the department for an outstanding research publication in Obstetrics & Gynecology (PMID 32541288).

Dr. Einerson is a nationally recognized clinical expert in diagnosis and management of placenta accreta spectrum disorders (PAS). He is Director of the Utah Placenta Accreta Program at the University of Utah. As one of the busiest referral programs for PAS in the United States, the program provides internationally recognized, cutting-edge, interdisciplinary approaches to diagnosis, treatment, patient-centered support for those affected by PAS. He is a Board Member of the Pan-American Society for Placenta Accreta Spectrum (PAS2) and serves as that society’s Publications Committee Chair. In 2020 and 2021, he was co-director of the Society of Maternal Fetal Medicine (SMFM) Accreta Scientific Forum. In October 2022, he and the University of Utah hosted the 4th Annual National meeting of PAS2 in Salt Lake City, Utah. Given this expertise, he has been a speaker, lecturer, and podcast guest to discuss PAS for regional and national events including SMFM Post-Graduate Courses and Accreta Scientific Forum, the PAS2 National Conference, the Vanderbilt High Risk Pregnancy Seminar, the Park City Postgraduate OB-GYN Course, the Healthful Woman Podcast, and CREOGs Over Coffee Podcast.

Dr. Einerson is an engaged leader, award-winning educator, and effective mentor. He was a member of the SMFM Patient Safety and Quality Committee from 2016 to 2022, where he authored the SMFM Placenta Accreta Spectrum Safety Checklist. Locally, he is the Medical Director of Obstetric Emergency Services (OBES) at University of Utah Health, Chair of the University of Utah Severe Maternal Morbidity Review Committee, and Member of the University Transfusion Committee. He is Associate Program Director (Research) for the University of Utah Maternal-Fetal Medicine (MFM) Fellowship.

A devoted medical educator, he has received eight teaching awards from medical students and residents, including twice being named the recipient of the National Faculty Award from the American College of Obstetricians and Gynecologists (ACOG) and Council on Resident Education in Obstetrics & Gynecology (CREOG) for promoting high standards of residency education in the field of obstetrics and gynecology.

Link to his research at: Google Scholar | Scopus | ORCID

 

Board Certification and Academic Information

Academic Departments Obstetrics & Gynecology -Associate Professor
Academic Divisions Maternal Fetal Medicine
Board Certification
American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)
American Board of Obstetrics & Gynecology

Education history

Undergraduate Biology - Bethel University B.S.
Professional Medical Medicine - Wake Forest University School of Medicine M.D.
Graduate Training Health Care Leadership Program - University of North Carolina, Gillings School of Global Public Health M.P.H.
Residency Obstetrics and Gynecology - Northwestern University Feinberg School of Medicine Resident
Chief Resident Obstetrics and Gynecology - Northwestern University Feinberg School of Medicine Chief Resident
Fellowship Maternal-Fetal Medicine - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Einerson BD, Miller ES, Grobman WA (2015). Does a postpartum hemorrhage patient safety program result in sustained changes in management and outcomes? Am J Obstet Gynecol, 212(2), 140-4.e1.
  2. Einerson BD, Grobman WA, Miller ES (2016). Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol, 215(1), 100.e1-7.
  3. Sudhof LS, Shainker SA, Einerson B (2019). Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis. American journal of obstetrics and gynecology, 221(3), 275.e1-275.e12.
  4. Einerson BD, Son M, Schneider P, Fields I, Miller E (2017). The association between intrauterine balloon tamponade duration and postpartum hemorrhage outcomes. American journal of obstetrics and gynecology, 216(3), 300.e1-300.e5.
  5. Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver R (2018). Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. American journal of obstetrics and gynecology, 218(6), 618.e1-618.e7.
  6. Monson M, Heuser C, Einerson BD, Esplin I, Snow G, Varner M, Esplin M (2020). Evaluation of an external fetal electrocardiogram monitoring system: a randomized controlled trial. American journal of obstetrics and gynecology, 223(2), 244.e1-244.e12.
  7. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, D'Alton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi S (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. American journal of obstetrics and gynecology, 223(3), 433.e1-433.e14.
  8. Son M, Einerson BD, Schneider P, Fields IC, Grobman WA, Miller E (2017). Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure?. American journal of perinatology, 34(2), 164-168.
  9. Son SL, Benson AE, Hart Hayes E, Subramaniam A, Clark EAS, Einerson B (2020). Outpatient Cervical Ripening: A Cost-Minimization and Threshold Analysis. American journal of perinatology, 37(3), 245-251.
  10. Einerson BD, Rodriguez CE, Silver RM, Donnelly MA, Kennedy AM, Woodward P (2020). Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders. American journal of perinatology, 38(9), 960-967.
  11. Grover B, Einerson BD, Keenan KD, Gibbins KJ, Callaway E, Lopez S, Silver R (2020). Patient-Reported Health Outcomes and Quality of Life after Peripartum Hysterectomy for Placenta Accreta Spectrum. American journal of perinatology,
  12. Kuramoto G, Hammad IA, Einerson BD, Allshouse AA, Debbink M, Grainger DW, Silver RM, Okano (2020). Human Mesenchymal Stem Cell Sheets Improve Uterine Incision Repair in a Rodent Hysterotomy Model. American journal of perinatology, 39(11), 1212-1222.
  13. Swanson K, Letourneau JM, Kuppermann M, Einerson B (2021). Obstetric morbidity in gestational carrier pregnancies: a population-based study. Journal of assisted reproduction and genetics, 38(1), 177-183.
  14. Swanson K, Debbink M, Letourneau JM, Kuppermann M, Einerson B (2021). Association of multifetal gestation with obstetric and neonatal outcomes in gestational carrier pregnancies. Journal of assisted reproduction and genetics, 38(3), 661-667.
  15. Miller ES, Einerson B, Sahabi S, Grobman W (2014). Association between second-trimester cervical length and cesarean delivery in multiparas. Journal of ultrasound in medicine, 33(10), 1733-6.
  16. Lee W, Fox KA, Cassady CI, Collins S, Einerson BD, Hobson SR, Palacios-Jaraquemada JM, Shrivastava V (2021). Placenta Accreta Spectrum 2021: Roundtable Discussion. Journal of ultrasound in medicine,
  17. Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EA (2019). Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths. Obstetrics and gynecology, 133(6), 1131-1140.
  18. Einerson BD, Stehlikova Z, Nelson RE, Bellows BK, Kawamoto K, Clark EA (2017). Transfusion Preparedness Strategies for Obstetric Hemorrhage: A Cost-Effectiveness Analysis. Obstetrics and gynecology, 130(6), 1347-1355.
  19. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstetrics and gynecology, 135(5), 1104-1111.
  20. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstetrics and gynecology, 136(1), 19-25.
  21. Swanson K, Letourneau JM, Kuppermann M, Einerson B (2020). Association of Obstetric and Neonatal Outcomes With Deviation From Guidelines for Gestational Carriers. Obstetrics and gynecology, 136(2), 387-393.
  22. Swanson K, Letourneau JM, Kuppermann M, Einerson B (2020). Reproductive Travel of Intended Parents for Delivery of Gestational Carrier Pregnancies. Obstetrics and gynecology, 136(3), 591-596.
  23. Carusi DA, Fox KA, Lyell DJ, Perlman NC, Aalipour S, Einerson BD, Belfort MA, Silver RM, Shamshirsaz A (2020). Placenta Accreta Spectrum Without Placenta Previa. Obstetrics and gynecology, 136(3), 458-465.
  24. Einerson BD, Grobman W (2020). Elective induction of labor: friend or foe?. Seminars in perinatology, 44(2), 151214.
  25. Einerson B (2019). QALYs in obstetrics: not the whole story. BJOG, 126(10), 1251.
  26. Einerson (2020). Are there any good data to support outpatient cervical ripening?. BJOG, 127(5), 580.
  27. Einerson B (2020). Should patients in the third trimester with a history of bariatric surgery receive growth ultrasound?. BJOG, 127(7), 847.
  28. Ibrahim Y, Einerson B, Carrell DT, Emery BR, Johnstone (2021). The hamster egg penetration test may decrease intracytoplasmic sperm injection utilization while maintaining high conventional fertilization rates. Asian journal of andrology, 23(1), 11-15.
  29. Gibbins KJ, Einerson BD, Varner MW, Silver R (2018). Placenta previa and maternal hemorrhagic morbidity. The journal of maternal-fetal & neonatal medicine, 31(4), 494-499.
  30. Einerson BD, Weiniger C (2021). Placenta accreta spectrum disorder: updates on anesthetic and surgical management strategies. International journal of obstetric anesthesia, 46, 102975.
  31. Bortoletto P, Einerson BD, Miller ES, Milad M (2015). Cost-Effectiveness Analysis of Morcellation Hysterectomy for Myomas. Journal of minimally invasive gynecology, 22(5), 820-6.
  32. Bortoletto P, Einerson BD, Miller ES, Milad M (2015). A Cost-Effectiveness Analysis of Morcellation Hysterectomy for Fibroids. Journal of minimally invasive gynecology, 22(6S), S58.
  33. Einerson BD, Huffman JK, Istwan NB, Rhea DJ, Joy S (2011). New gestational weight gain guidelines: an observational study of pregnancy outcomes in obese women. Obesity (Silver Spring, Md.), 19(12), 2361-4.
  34. Wu J, Einerson B, Shaw JM, Nygaard IE, Sheng X, Wolpern A, Egger M (2019). Association between sleep quality and physical activity in postpartum women. Sleep health, 5(6), 598-605.
  35. Bruno AM, Olmsted MW, Martin V, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue N (2021). Rigor, reproducibility, and transparency of randomized controlled trials in obstetrics and gynecology. American journal of obstetrics & gynecology MFM, 3(6), 100450.
  36. Bruno AM, Shea AE, Einerson BD, Metz TD, Allshouse AA, Scott JR, Blue N (2021). Impact of the p-Value Threshold on Interpretation of Trial Outcomes in Obstetrics and Gynecology. American journal of perinatology, 38(12), 1223-1230.
  37. Combs CA, Einerson BD, Toner LE, Patient Safety and Quality Committee, Society for Maternal-Fetal Medicine. Electronic address: smfm@smfm.or (2021). Society for Maternal-Fetal Medicine Special Statement: Surgical safety checklists for cesarean delivery. American journal of obstetrics and gynecology, 225(5), B43-B49.
  38. Einerson BD, Silver RM, Jauniaux (2021). Placenta accreta spectrum: welcome progress and a call for standardisation. BJOG, 128(10), 1656-1657.
  39. Afshar Y, Dong J, Zhao P, Li L, Wang S, Zhang RY, Zhang C, Yin O, Han CS, Einerson BD, Gonzalez TL, Zhang H, Zhou A, Yang Z, Chou SJ, Sun N, Cheng J, Zhu H, Wang J, Zhang TX, Lee YT, Wang JJ, Teng PC, Yang P, Qi D, Zhao M, Sim MS, Zhe R, Goldstein JD, Williams J 3rd, Wang X, Zhang Q, Platt LD, Zou C, Pisarska MD, Tseng HR, Zhu (2021). Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders. Nature communications, 12(1), 4408.
  40. Benson AE, Metcalf RA, Cail K, Rollins MD, Warrick CM, Falkner D, Clark EAS, Nelson RE, Einerson B (2021). Transfusion Preparedness in the Labor and Delivery Unit: An Initiative to Improve Safety and Cost. Obstetrics and gynecology, 138(5), 788-794.
  41. Einerson BD, Watt MH, Sartori B, Silver R, Rothwell (2021). Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semi-structured interviews. BMJ open, 11(11), e052766.
  42. Arslan E, Einerson BD, Zhang J, Zhang J, Branch D (2024). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. American journal of perinatology, 41(1), 89-97.
  43. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson B (2022). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. American journal of perinatology, 39(6), 567-576.
  44. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver R (2022). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstetrics and gynecology, 139(3), 449-451.
  45. Jauniaux E, Hussein AM, Einerson BD, Silver R (2022). Debunking 20(th) century myths and legends about the diagnosis of placenta accreta spectrum. Ultrasound in obstetrics & gynecology, 59(4), 417-423.
  46. Richards DS, Benson AE, Einerson B (2022). Confirmatory Middle Cerebral Artery Doppler Testing in Alloimmunized Patients with Suspected Fetal Anemia. American journal of perinatology,
  47. Detlefs SE, Carusi DA, Modest AM, Einerson BD, Lyell D, Grace MR, Shrivastava VK, Khandelwal M, Salmanian B, Shainker SA, Fox KA, Subramaniam A, Crosland A, Duryea EL, Shamshirsaz AA, Shrestha K, Belfort MA, Silver RM, Clark SL, Shamshirsaz A (2023). The Association between Placenta Accreta Spectrum Severity and Incidence of Small for Gestational Age Neonates. American journal of perinatology, 40(1), 9-14.
  48. Hessami K, Salmanian B, Einerson BD, Carusi DA, Shamshirsaz AA, Shainker SA, Subramaniam A, Shrivastava VK, Nieto-Calvache AJ, Gilner JB, Khandelwal M, Backer-Meurke S, Cimic A, Aalipour S, Grace MR, Fox KA, Lyell DJ, Belfort MA, Silver RM, Shamshirsaz A (2022). Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. Obstetrics and gynecology, 140(4), 599-606.
  49. Bridges AG, Allshouse AA, Canfield DR, Grover BW, Son SL, Einerson BD, Silver RM, Haas DM, Grobman WA, Simhan HN, Day RC, Blue N (2022). Association of Prostaglandin Use for Cervical Ripening with Mode of Delivery in Small for Gestational Age versus Non-Small for Gestational Age Neonates. American journal of perinatology,
  50. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson B (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and gynecology, 140(5), 806-811.
  51. Salmanian B, Einerson BD, Carusi DA, Shainker SA, Nieto-Calvache AJ, Shrivastava VK, Subramaniam A, Zuckerwise LC, Lyell DJ, Khandelwal M, Fitzgerald GD, Hessami K, Fox KA, Silver RM, Shamshirsaz A (2022). Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience. American journal of obstetrics & gynecology MFM, 4(6), 100718.
  52. Saunders SJ, Grisamore JL, Wong T, Torrejon Torres R, Saunders R, Einerson (2022). Moving preinduction cervical ripening to a lower acuity inpatient setting using the synthetic hygroscopic cervical dilator: a cost-consequence analysis for the United States. Journal of medical economics, 25(1), 1185-1198.
  53. Einerson BD, Nelson R, Botto LD, Minich LL, Krikov S, Waitzman N, Pinto N (2022). Prenatally diagnosed congenital heart disease: the cost of maternal care. The journal of maternal-fetal & neonatal medicine, 35(26), 10428-10434.
  54. McLaughlin HD, Benson AE, Scaglione MA, Saviers-Steiger JS, Canfield DR, Debbink MP, Silver RM, Einerson B (2022). Association between short interpregnancy interval and placenta accreta spectrum. AJOG global reports, 2(2), 100051.
  55. Jauniaux E, D'Antonio F, Bhide A, Prefumo F, Silver RM, Hussein AM, Shainker SA, Chantraine F, Alfirevic Z, Delphi consensus expert pane (2023). Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound in obstetrics & gynecology, 61(4), 518-525.
  56. Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward P (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstetrics and gynecology, 141(3), 544-554.
  57. Jauniaux E, Fox KA, Einerson B, Hussein AM, Hecht JL, Silver R (2023). Perinatal assessment of complex cesarean delivery: beyond placenta accreta spectrum. American journal of obstetrics and gynecology, 229(2), 129-139.
  58. Gatta LA, Ellestad SC, Boyd BK, Collins S, Einerson BD, Stephenson ML, Hammad I, Varvoutis MS, Honart AW, Federspiel JJ, Craig AM, Swartz A, Salinaro JR, Unnithan S, Weber J, Erkanli A, Gilner J (2023). Validation of a sonographic checklist for the detection of histologic placenta accreta spectrum. American journal of obstetrics & gynecology MFM, 5(8), 101017.
  59. Einerson BD, Gilner JB, Zuckerwise L (2023). Placenta Accreta Spectrum. Obstetrics and gynecology, 142(1), 31-50.
  60. Khandelwal M, Shipp TD, Zelop CM, Abuhamad AZ, Afshar Y, Einerson BD, Fox KA, Huisman TAGM, Lyell DJ, Perni U, Platt LD, Shainker SA, Pan American Society for Placenta Accreta Spectrum (PAS2 (2023). Imaging the Uterus in Placenta Accreta Spectrum Disorder. American journal of perinatology, 40(9), 1013-1025.
  61. Einerson BD, Shamshirsaz AA, Stephenson ML, Khandelwal M, Holt R, Duzyj CM, Shrivastava V (2023). The Need for Presurgical Evaluation for Placenta Accreta Spectrum. American journal of perinatology, 40(9), 996-1001.
  62. Khoury-Collado F, Newton JM, Brook OR, Carusi DA, Shrivastava VK, Crosland BA, Fox KA, Khandelwal M, Karam AK, Bennett KA, Sandlin AT, Shainker SA, Einerson BD, Belfort MA, Pan-American Society for Placenta Accreta Spectru (2023). Surgical Techniques for the Management of Placenta Accreta Spectrum. American journal of perinatology, 40(9), 970-979.
  63. Monson MA, Chmait RH, Einerson (2023). Fetoscopic Laser Ablation of Type II Vasa Previa: A Cost Benefit Analysis. American journal of perinatology,
  64. Society for Maternal-Fetal Medicine (SMFM), Einerson BD, Healy AJ, Lee A, Warrick C, Combs CA, Hameed AB, SMFM Patient Safety and Quality Committee. Electronic address: smfm@smfm.or (2024). Society for Maternal-Fetal Medicine Special Statement: Emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum. American journal of obstetrics and gynecology, 230(1), B2-B11.
  65. Bruno AM, Federspiel JJ, McGee P, Pacheco LD, Saade GR, Parry S, Longo M, Tita ATN, Gyamfi-Bannerman C, Chauhan SP, Einerson BD, Rood K, Rouse DJ, Bailit J, Grobman WA, Simhan HN, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Networ (2024). Validation of Three Models for Prediction of Blood Transfusion during Cesarean Delivery Admission. American journal of perinatology, 41(S 01), e3391-e3400.
  66. Modest AM, Einerson BD, Nieto AJ, Shrivastava VK, Shamshirsaz AA, Shainker SA, Pan American Society for Placenta Accreta Spectru (2024). Risk Profiling In Vitro Fertilization Pregnancies that Develop Placenta Accreta Spectrum. American journal of perinatology,
  67. Munoz JL, Einerson BD, Silver RM, Mulampurath S, Sherman LS, Rameshwar P, Prewit EB, Ramsey P (2024). Serum exosomal microRNA pathway activation in placenta accreta spectrum: pathophysiology and detection. AJOG global reports, 4(1), 100319.

Review

  1. Einerson BD, Sandlin AT, Afshar Y, Sharawi N, Fox KA, Newton JM, Shainker SA, Pezeshkmehr A, Carusi DA, Moroz (2023). General Management Considerations for Placenta Accreta Spectrum. American journal of perinatology, 40(9), 1026-1032.
  2. Javinani A, Qaderi S, Hessami K, Shainker SA, Shamshirsaz AA, Fox KA, Mustafa HJ, Subramaniam A, Khandelwal M, Sandlin AT, Duzyj CM, Lyell DJ, Zuckerwise LC, Newton JM, Kingdom JC, Harrison RK, Shrivastava VK, Greiner AL, Loftin R, Genc MR, Atasi LK, Abdel-Razeq SS, Bennett KA, Carusi DA, Einerson BD, Gilner JB, Carver AR, Silver RM, Shamshirsaz A (2024). Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. American journal of obstetrics and gynecology, 230(5), 485-492.e7.
  3. Fitzgerald GD, Newton JM, Atasi L, Buniak CM, Burgos-Luna JM, Burnett BA, Carver AR, Cheng C, Conyers S, Davitt C, Deshmukh U, Donovan BM, Easter SR, Einerson BD, Fox KA, Habib AS, Harrison R, Hecht JL, Licon E, Nino JM, Munoz JL, Nieto-Calvache AJ, Polic A, Ramsey PS, Salmanian B, Shamshirsaz AA, Shamshirsaz AA, Shrivastava VK, Woolworth MB, Yurashevich M, Zuckerwise L, Shainker SA, Pan-American Society for Placenta Accreta Spectru (2024). Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. American journal of obstetrics & gynecology MFM, 6(1), 101229.

Editorial

  1. Einerson B (2023). Conservative management for placenta accreta spectrum: questions and barriers remain but are surmountable. American journal of obstetrics & gynecology MFM, 5(3), 100859.

Letter

  1. Shamshirsaz AA, Carusi D, Shainker SA, Einerson B, Khandelwal M, Erfani H, Shamshirsaz AA, Modest AM, Aalipour S, Fox KA, Lyell DJ, Belfort MA, Silver R (2020). Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the Pan American Society for Placenta Accreta Spectrum (PAS2). American journal of obstetrics and gynecology, 222(6), 624-625.
  2. Einerson B (2018). How would you help a colleague dealing with the stress of an adverse outcome? A report from #BlueJC. BJOG, 125(8), 1044.
  3. Einerson B (2018). A report from #BlueJC: Would you recommend cranberry capsules to prevent postoperative bacteriuria?. BJOG, 125(1), 98.
  4. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz T (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. American journal of obstetrics & gynecology MFM, 4(4), 100620.
  5. Einerson BD, Allshouse AA, Sandoval G, Nelson RE, Esplin MS, Varner M, Grobman WA, Metz TD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Networ (2024). Source of variation in cost of obstetrical care for low-risk nulliparas at term. American journal of obstetrics and gynecology, 230(5), e99-e100.

Video/Film/CD/Web/Podcast

  1. Falkner J, Einerson (2017). Nights and Weekends on the Maternity Ward.

News & Podcasts

News